Highways and Detours in the Realm of Photodynamic Therapy

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 Mar 28

PMID 38542092

Authors

David Kessel

Qian Peng

Affiliations

Soon will be listed here.

Abstract

Photodynamic therapy (PDT) has been a topic of interest since the first report in 1900 but has yet to become a 'mainstream' treatment protocol in the medical field. There are clear indications for which PDT might be the 'method of choice', but it is unlikely that there will be protocols for the treatment of systemic disease. This report discusses recent developments for promoting PDT efficacy, in the context of what is already known. Factors that can limit the scope of these applications are also indicated. Among the more interesting of these developments is the use of formulation techniques to target specific organelles for photodamage. This can enhance responses to PDT and circumvent situations where an impaired death pathway interferes with PDT efficacy.

References

Farber S . Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer. Blood. 1949; 4(2):160-7. View

Lee D, Ko H, Kim A . Lipid profile and survival time in patients with terminal cancer: a cross-sectional study. Ann Palliat Med. 2022; 11(10):3075-3084. DOI: 10.21037/apm-22-366. View

Celli J, Rizvi I, Evans C, Abu-Yousif A, Hasan T . Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model. J Biomed Opt. 2010; 15(5):051603. PMC: 2948043. DOI: 10.1117/1.3483903. View

Morton C, Szeimies R, Sidoroff A, Braathen L . European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma. J Eur Acad Dermatol Venereol. 2012; 27(5):536-44. DOI: 10.1111/jdv.12031. View

Rodriguez M, Zhang P, Azizuddin K, Delos Santos G, Chiu S, Xue L . Structural factors and mechanisms underlying the improved photodynamic cell killing with silicon phthalocyanine photosensitizers directed to lysosomes versus mitochondria. Photochem Photobiol. 2009; 85(5):1189-200. PMC: 3351115. DOI: 10.1111/j.1751-1097.2009.00558.x. View

Alexopoulos C, Blatsios B, Avgerinos A . Serum lipids and lipoprotein disorders in cancer patients. Cancer. 1987; 60(12):3065-70. DOI: 10.1002/1097-0142(19871215)60:12<3065::aid-cncr2820601234>3.0.co;2-q. View

Christensen E, Foss O, Quist-Paulsen P, Staur I, Pettersen F, Holien T . Application of Photodynamic Therapy with 5-Aminolevulinic Acid to Extracorporeal Photopheresis in the Treatment of Patients with Chronic Graft-versus-Host Disease: A First-in-Human Study. Pharmaceutics. 2021; 13(10). PMC: 8538664. DOI: 10.3390/pharmaceutics13101558. View

Selman S, Klaunig J, Goldblatt P, Keck R, Britton S . Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res. 1984; 44(5):1924-7. View

Kennedy J, Pottier R . Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B. 1992; 14(4):275-92. DOI: 10.1016/1011-1344(92)85108-7. View

10.

Morton C, Szeimies R, Sidoroff A, Braathen L . European guidelines for topical photodynamic therapy part 2: emerging indications--field cancerization, photorejuvenation and inflammatory/infective dermatoses. J Eur Acad Dermatol Venereol. 2012; 27(6):672-9. DOI: 10.1111/jdv.12026. View

11.

Peng Q, Moan J, Nesland J . Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct Pathol. 1996; 20(2):109-129. DOI: 10.3109/01913129609016306. View

12.

Agarwal M, Clay M, Harvey E, Evans H, Antunez A, Oleinick N . Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 1991; 51(21):5993-6. View

13.

Cincotta L, Szeto D, Lampros E, Hasan T, Cincotta A . Benzophenothiazine and benzoporphyrin derivative combination phototherapy effectively eradicates large murine sarcomas. Photochem Photobiol. 1996; 63(2):229-37. DOI: 10.1111/j.1751-1097.1996.tb03019.x. View

14.

Munegowda M, Manalac A, Weersink M, Cole H, McFarland S, Lilge L . Ru(II) CONTAINING PHOTOSENSITIZERS FOR PHOTODYNAMIC THERAPY: A CRITIQUE ON REPORTING AND AN ATTEMPT TO COMPARE EFFICACY. Coord Chem Rev. 2023; 470. PMC: 9850455. DOI: 10.1016/j.ccr.2022.214712. View

15.

Taverne Y, Bogers A, Duncker D, Merkus D . Reactive oxygen species and the cardiovascular system. Oxid Med Cell Longev. 2013; 2013:862423. PMC: 3655680. DOI: 10.1155/2013/862423. View

16.

Peng Q, Moan J, Warloe T, Iani V, Steen H, Bjorseth A . Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B. 1996; 34(1):95-6. DOI: 10.1016/1011-1344(95)07268-3. View

17.

Pandey R, Siegel M, Tsao R, McReynolds J, Dougherty T . Fast atom bombardment mass spectral analyses of Photofrin II and its synthetic analogs. Biomed Environ Mass Spectrom. 1990; 19(7):405-14. DOI: 10.1002/bms.1200190705. View

18.

Sperandio S, de Belle I, Bredesen D . An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A. 2000; 97(26):14376-81. PMC: 18926. DOI: 10.1073/pnas.97.26.14376. View

19.

Stummer W, Pichlmeier U, Meinel T, Wiestler O, Zanella F, Reulen H . Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7(5):392-401. DOI: 10.1016/S1470-2045(06)70665-9. View

20.

Rizvi I, Obaid G, Bano S, Hasan T, Kessel D . Photodynamic therapy: Promoting in vitro efficacy of photodynamic therapy by liposomal formulations of a photosensitizing agent. Lasers Surg Med. 2018; 50(5):499-505. PMC: 7449601. DOI: 10.1002/lsm.22813. View